This brand name is authorized in Canada, Cyprus, Spain, Finland, Hong Kong, Croatia, Ireland, Japan, Malta, New Zealand, Poland, Singapore, United Kingdom, United States
The drug GASTROGRAFIN contains a combination of these active pharmaceutical ingredients (APIs):
1
Sodium amidotrizoate
UNII V5403H8VG7 - DIATRIZOATE SODIUM
|
|
2
Meglumine amidotrizoate
UNII 3X9MR4N98U - DIATRIZOATE MEGLUMINE
|
|
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
GASTROGRAFIN Gastroenteral solution | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
P01CB01 | Meglumine antimonate | P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01C Agents against leishmaniasis and trypanosomiasis → P01CB Antimony compounds |
V08AA01 | Diatrizoic acid | V Various → V08 Contrast media → V08A X-ray contrast media, iodinated → V08AA Watersoluble, nephrotropic, high osmolar X-ray contrast media |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: CA | Health Products and Food Branch | Identifier(s): 02228564 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 36270 |
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 027102 |
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 97577 |
Country: HK | Department of Health Drug Office | Identifier(s): 46076 |
Country: HR | Agencija za lijekove i medicinske proizvode | Identifier(s): HR-H-901124749 |
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 7211001X1030 |
Country: MT | Medicines Authority | Identifier(s): AA565/52601, MA1354/00201 |
Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 2521 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100025994, 100293631 |
Country: SG | Health Sciences Authority | Identifier(s): 05846P |
Country: US | FDA, National Drug Code | Identifier(s): 0270-0445 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.